Share this
is dried blood a biohazard?
by Neoteryx Microsampling on Apr 9, 2018 6:06:00 AM
Working with traditional wet blood specimens has always raised safety concerns and posed logistical challenges. Blood sample storage and cold chain shipping of biofluid samples requires navigating a complicated maze of regulatory issues that require wet blood samples to be handled as a biohazard. It's no wonder that dried blood sampling techniques have emerged in the last few decades as a preferable alternative to wet sampling, in many cases.
Working with wet blood, collected using traditional venipuncture methods, brings with it the full range of obligations associated with handling and disposing of biohazardous materials – not to mention the significant risks.
By contrast, dried blood handling is not considered to be as hazardous and, therefore, is not subjected to the same stringent biohazard requirements.
The Centers for Disease Control and Prevention (CDC) has updated its guidelines around handling and shipping dried blood specimens. While important safety precautions must be recognized and put in place, the guidelines for handling dried capillary blood specimens are not as rigorous as those for wet blood and other serious biohazards. Clearly, dried blood is not considered a biohazard in the same way that wet blood is.
How are dried blood samples shipped?
Blood samples collected using volumetric microsampling devices like the hemaPEN® or the Mitra® device with VAMS® technology are considered stable at ambient temperatures. This means that the dried blood samples don't require cold storage, special handling or cold shipping.
Research scientists and care providers can send these volumetric microsampling devices in sample collection kit boxes to people at home for remote sample collection.
After using the kits and devices for blood sample collection in a remote setting, the sampled devices can be closed inside their plastic casing and sealed inside a foil specimen bag.
The sealed specimen bag can be placed inside the provided shipping envelope and mailed to the laboratory via standard post.
The envelope and the microsampling device sealed inside it are not considered a risk during shipping, because the specimens are dried and closed up inside the device container.
Per CDC guidelines, taking and sending capillary blood samples is easier, but the process may still have its challenges. Fortunately, Mitra Microsample Collection Kits include detailed instructions and all the supplies needed for collecting volumetrically accurate blood samples anywhere, at any time.
Virtually anyone can collect a remote blood sample using these finger-stick sampling kits, with minimal training.
The kits can be fully customized to include instructions in multiple languages, with web links to training videos, or to meet other requirements of research study managers or clinical trial managers.
Research scientists around the globe have transitioned to dried blood microsampling in their studies to avoid the costs and complexities of storing and shipping wet blood as a biohazard.
Visit our resource pages to learn more about dried blood microsampling.
Image credits: Trajan, Neoteryx, iStock
Share this
- Microsampling (206)
- Research, Remote Research (118)
- Venipuncture Alternative (106)
- Clinical Trials, Clinical Research (83)
- Mitra® Device (73)
- Therapeutic Drug Monitoring, TDM (50)
- Dried Blood Spot, DBS (38)
- Biomonitoring, Health, Wellness (31)
- Infectious Disease, Vaccines, COVID-19 (24)
- Decentralized Clinical Trial (DCT) (22)
- Blood Microsampling, Serology (21)
- Omics, Multi-Omics (19)
- Specimen Collection (17)
- Toxicology, Doping, Drug/Alcohol Monitoring, PEth (17)
- hemaPEN® Device (13)
- Preclinical Research, Animal Studies (12)
- Pharmaceuticals, Drug Development (9)
- Harpera® Tool (7)
- Skin Microsampling, Microbiopsy (6)
- Industry News, Microsampling News (5)
- Antibodies, MAbs (3)
- Company Press Release, Product Press Release (3)
- Environmental Toxins, Exposures (1)
- June 2024 (1)
- May 2024 (1)
- April 2024 (4)
- March 2024 (1)
- February 2024 (2)
- January 2024 (4)
- December 2023 (3)
- November 2023 (3)
- October 2023 (3)
- September 2023 (3)
- July 2023 (3)
- June 2023 (2)
- April 2023 (2)
- March 2023 (2)
- February 2023 (2)
- January 2023 (3)
- December 2022 (2)
- November 2022 (3)
- October 2022 (4)
- September 2022 (3)
- August 2022 (5)
- July 2022 (2)
- June 2022 (2)
- May 2022 (4)
- April 2022 (3)
- March 2022 (3)
- February 2022 (4)
- January 2022 (5)
- December 2021 (3)
- November 2021 (5)
- October 2021 (3)
- September 2021 (3)
- August 2021 (4)
- July 2021 (4)
- June 2021 (4)
- May 2021 (4)
- April 2021 (3)
- March 2021 (5)
- February 2021 (4)
- January 2021 (4)
- December 2020 (3)
- November 2020 (5)
- October 2020 (4)
- September 2020 (3)
- August 2020 (3)
- July 2020 (6)
- June 2020 (4)
- May 2020 (4)
- April 2020 (3)
- March 2020 (6)
- February 2020 (3)
- January 2020 (4)
- December 2019 (5)
- November 2019 (4)
- October 2019 (2)
- September 2019 (4)
- August 2019 (4)
- July 2019 (3)
- June 2019 (7)
- May 2019 (6)
- April 2019 (5)
- March 2019 (6)
- February 2019 (5)
- January 2019 (8)
- December 2018 (3)
- November 2018 (4)
- October 2018 (7)
- September 2018 (6)
- August 2018 (5)
- July 2018 (8)
- June 2018 (6)
- May 2018 (5)
- April 2018 (6)
- March 2018 (4)
- February 2018 (6)
- January 2018 (4)
- December 2017 (2)
- November 2017 (3)
- October 2017 (2)
- September 2017 (4)
- August 2017 (2)
- July 2017 (4)
- June 2017 (5)
- May 2017 (6)
- April 2017 (6)
- March 2017 (5)
- February 2017 (4)
- January 2017 (1)
- July 2016 (3)
- May 2016 (1)
- April 2016 (2)
Comments (2)